Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
(NASH)
.
Show all posts
Showing posts with label
(NASH)
.
Show all posts
Wednesday, September 11, 2024
FDA Grants Accelerated Approval for Rezdiffra (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH)
›
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohe...
›
Home
View web version
